Company profile
Home | GSK
At GSK, we unite science, technology and talent to get ahead of disease together
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
CH03 | Transaction MzQzNjY4MTA2NmFkaXF6a2N4
Published 24 Sep 2024 05:37
CH01 | Transaction MzQzNjY4MTE2MGFkaXF6a2N4
Published 23 Sep 2024 06:48
CH01 | Transaction MzQzNjY4MTEzOWFkaXF6a2N4
Published 23 Sep 2024 06:44
CH01 | Transaction MzQzNjU1MjM2OGFkaXF6a2N4
Published 20 Sep 2024 10:29
CH01 | Transaction MzQzNjAzMjYzN2FkaXF6a2N4
Published 17 Sep 2024 07:04
CH01 | Transaction MzQzNjAzMjExNGFkaXF6a2N4
Published 17 Sep 2024 06:54
CH01 | Transaction MzQzNjAzMDY0MmFkaXF6a2N4
Published 17 Sep 2024 06:39
AD01 | Transaction MzQzNTIyMjQxOGFkaXF6a2N4
Published 11 Sep 2024 02:01
AP01 | Transaction MzQzMzY2NTg5M2FkaXF6a2N4
Published 29 Aug 2024 09:55
CS01 | Transaction MzQzMjMzNzE3MGFkaXF6a2N4
Published 15 Aug 2024 10:07
AA | Transaction MzQzMTYzMDU0MWFkaXF6a2N4 | Paper/PDF filed
Published 16 Aug 2024 12:22
Company registered at Companies House
1 Aug 2016 to 31 Jan 2019
Current safety methods for product release such as the compendial sterility test are inadequate for a large number of autologous cell and gene therapy products due to their short shelf life. This problem is exacerbated by the long complex manufacturing processes during which microbial contamination can occur. As a result sterility testing has to be perfor...
